Instrument Inactif

Communiqués BIOLASE Inc Nasdaq

Actions

US0909111082

Sociétés holdings

Communiqués

14/10/25	BIOLASE Showcases Breakthrough YSGG Laser Protocol for Predictable Periodontitis Treatment at AAP 2025	PR
08/11/24	Biolase: Q3 Earnings Snapshot	AQ
08/11/24	BIOLASE : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
01/10/24	BIOLASE : Voluntarily Initiates Chapter 11 Proceedings Form 8 K	PU
08/08/24	Biolase: Q2 Earnings Snapshot	AQ
22/07/24	BIOLASE : Private Placement Form 8 K	PU
17/05/24	BIOLASE : Failure to Satisfy Listing Rule - Form 8-K	PU
13/05/24	Biolase: Q1 Earnings Snapshot	AQ
21/03/24	Biolase: Q4 Earnings Snapshot	AQ
15/03/24	BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2023 RESULTS ON MARCH 21, 2024	AQ
23/02/24	BIOLASE LAUNCHES STATE-OF-THE-ART ALL-TISSUE LASER SYSTEM TO ACCELERATE ADOPTION OF LASERS IN DENTISTRY	AQ
21/02/24	BIOLASE ANNOUNCES FIRST QUARTER 2024 WEBINAR SERIES 'LETS TALK DENTAL'	AQ
15/02/24	BIOLASE, INC. GRANTED EXTENSION BY NASDAQ TO REGAIN COMPLIANCE WITH THE STOCKHOLDERS EQUITY CONTINUED LISTING REQUIREMENT	AQ
30/01/24	BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024	AQ
06/12/23	BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	PR
09/11/23	Biolase: Q3 Earnings Snapshot	AQ
09/11/23	BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES	PR
09/11/23	LANDMARK STUDY PERFORMED BY THE INDEPENDENT MCGUIRE INSTITUTE CONFIRMS POSITIVE 12 MONTH CLINICAL OUTCOMES FOR BIOLASE REPAIR PERIO PROTOCOL	AQ
18/09/23	BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants	PR
14/09/23	BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants	PR
10/08/23	Biolase: Q2 Earnings Snapshot	AQ
13/06/23	BIOLASE, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
05/06/23	BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK	PR
26/05/23	BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants	PR
24/05/23	BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants	PR